Does anyone know the reason for this? Perhaps acrux is being bought by another company? Perhaps one of their late-stage trials has failed? Surely they wouldn't go into a halt for bad results on one product? They have 29 million in savings, so it's not debt. I'm leaning towards good news!? i hope so.
But hey, none of you have even heard of acrux so i don't expect a reply.
Add to My Watchlist
What is My Watchlist?
